封面
市场调查报告书
商品编码
1268539

2023-2032 年全球肉毒桿菌毒素市场

Global Botulinum Toxin Market Forecast 2023-2032

出版日期: | 出版商: Inkwood Research | 英文 233 Pages | 商品交期: 2-3个工作天内

价格

在 2023 年至 2032 年的预测期内,全球肉毒桿菌毒素市场规模预计将以 10.07% 的复合年增长率增长。 对整容手术的需求不断增长、老年人口不断增长以及对非侵入性整容手术的需求正在推动市场增长。

本报告研究了全球肉毒桿菌毒素市场,并提供了全面的信息,包括市场动态、市场分析和竞争格局。

内容

第一章研究范围与研究方法

  • 调查目的
  • 调查方法
  • 假设和限制

第 2 章执行摘要

  • 市场规模/估计
  • 市场概览
  • 调查范围
  • 危机情景分析
    • COVID-19 对肉毒桿菌毒素市场的影响
  • 主要市场调查结果
    • 有利的监管批准有助于市场增长
    • 提高对“NOTOX”的认识
    • 美容旅游的扩张增加了对肉毒桿菌毒素的需求

第三章市场动态

  • 主要驱动力
    • 对整容手术的需求激增
    • 不断增长的老年人口
    • 对无创整容手术的需求不断增长
  • 主要製约因素
    • 对肉毒桿菌毒素不良反应的担忧
    • 缺乏支持整容手术的报销政策

第四章重点分析

  • 主要市场趋势
  • 波特的五力分析
    • 买家力量
    • 供应商的力量
    • 备选方案
    • 新人
    • 行业竞争
  • 规划增长前景
    • 美国增长前景图
    • 德国增长前景图
    • 中国的增长前景图
    • 巴西增长前景图
  • 市场成熟度分析
  • 市场集中度分析

第 5 章市场:按类型

  • A 型肉毒桿菌毒素
  • B 型肉毒桿菌毒素

第 6 章市场:用户细分

第 7 章市场:按应用

  • 医学
    • 慢性偏头痛
    • 肌肉痉挛
    • 膀胱过度活动症
    • 多汗症
    • 其他医疗应用
  • 美容
    • 眼角周围有皱纹
    • 额头皱纹
    • 眉毛皱纹/眉间
    • 下颌骨/咬肌角度
    • 其他美容用途

第 8 章市场:按最终用户分类

  • 专业和皮肤科诊所
  • 医院和诊所
  • 其他最终用户

第九章区域分析

  • 北美
  • 欧洲
  • 亚太地区
  • 世界其他地区

第10章竞争格局

  • 重大战略发展
    • 收购
    • 产品发布和开发
    • 伙伴关係
    • 业务扩展
  • 公司简介
    • ABBVIE
    • CANDELA MEDICAL
    • DAEWOONG PHARMACEUTICAL CO LTD
    • EVOLUS INC
    • GALDERMA
    • HUGEL INC
    • IPSEN
    • LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
    • MEDYTOX INC
    • MERZ PHARMA
    • REVANCE THERAPEUTICS INC
    • US WORLDMEDS LLC
Product Code: 38893

KEY FINDINGS

The global botulinum toxin market is predicted to record a 10.07% CAGR during the forecast period, 2023-2032. The surge in demand for aesthetic procedures, the rising geriatric population, and the demand for non-invasive cosmetic procedures driving the botulinum toxin market drive the market growth.

MARKET INSIGHTS

Botulinum toxin is a neurotoxin produced by certain Clostridium botulinum strains and is utilized for both therapeutic and cosmetic purposes. Its cosmetic form, commonly referred to as Botox by patients, is an injectable that temporarily reduces or eliminates wrinkles and fine lines on the face. The most frequently treated areas include frown lines, forehead wrinkles, and crow's feet around the eyes, but it is also used to treat other areas such as gummy smiles, lip lines, overactive jaw muscles, and thick neck bands.

Several factors, including increasing demand for aesthetic procedures, growth in non-invasive cosmetic procedures, research and development initiatives, and a rise in the geriatric population, are propelling the global market for botulinum toxin. With an increasing number of people worldwide undergoing aesthetic procedures each year, the market for botulinum toxin is expected to experience significant growth in the coming years.

REGIONAL INSIGHTS

The global botulinum toxin market analysis comprises a study of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to dominate the market due to the growing R&D efforts to broaden therapeutic uses and an increase in cosmetic issues like crow's feet and medial canthal wrinkles. Additionally, factors such as disposable personal income and per capita disposable income in the United States are expected to fuel the growth of the botulinum toxin market in North America.

COMPETITIVE INSIGHTS

Market players invest in R&D, label extension, and acquisitions to enhance product offerings. Innovation, advertising, competitive strategies, and high concentration ratio increase industry rivalry.

Major market players include Medytox, Merz Pharma, Lanzhou Institute of Biological Products Co Ltd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW
  • 2.3. SCOPE OF STUDY
  • 2.4. CRISIS SCENARIO ANALYSIS
    • 2.4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
  • 2.5. MAJOR MARKET FINDINGS
    • 2.5.1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
    • 2.5.2. GROWING AWARENESS ABOUT 'NOTOX'
    • 2.5.3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
    • 3.1.2. RISING GERIATRIC POPULATION
    • 3.1.3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
    • 3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES

4. KEY ANALYTICS

  • 4.1. KEY MARKET TRENDS
  • 4.2. PORTER'S FIVE FORCES ANALYSIS
    • 4.2.1. BUYERS POWER
    • 4.2.2. SUPPLIERS POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. GROWTH PROSPECT MAPPING
    • 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    • 4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
    • 4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
    • 4.3.4. GROWTH PROSPECT MAPPING FOR BRAZIL
  • 4.4. MARKET MATURITY ANALYSIS
  • 4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TYPE

  • 5.1. TYPE A BOTULINUM TOXIN
  • 5.2. TYPE B BOTULINUM TOXIN

6. MARKET BY USER DEMOGRAPHIC

  • 6.1. WOMEN
  • 6.2. MEN

7. MARKET BY APPLICATION

  • 7.1. MEDICAL
    • 7.1.1. CHRONIC MIGRAINE
    • 7.1.2. MUSCLE SPASM
    • 7.1.3. OVERACTIVE BLADDER
    • 7.1.4. HYPERHIDROSIS
    • 7.1.5. OTHER MEDICAL APPLICATIONS
  • 7.2. AESTHETIC
    • 7.2.1. CROW'S FEET
    • 7.2.2. FOREHEAD LINES
    • 7.2.3. FROWN LINES/GLABELLAR
    • 7.2.4. SQUARE JAW/MASSETER
    • 7.2.5. OTHER AESTHETIC APPLICATIONS

8. MARKET BY END-USER

  • 8.1. SPECIALTY AND DERMATOLOGY CLINICS
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
    • 9.1.3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
    • 9.1.4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
    • 9.1.5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
    • 9.1.6. COUNTRY ANALYSIS
      • 9.1.6.1. UNITED STATES
      • 9.1.6.1.1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.1.6.2. CANADA
      • 9.1.6.2.1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
    • 9.2.3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
    • 9.2.4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
    • 9.2.5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
    • 9.2.6. COUNTRY ANALYSIS
      • 9.2.6.1. UNITED KINGDOM
      • 9.2.6.1.1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.2. GERMANY
      • 9.2.6.2.1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.3. FRANCE
      • 9.2.6.3.1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.4. ITALY
      • 9.2.6.4.1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.5. SPAIN
      • 9.2.6.5.1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.6. NORDIC COUNTRIES
      • 9.2.6.6.1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.7. POLAND
      • 9.2.6.7.1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.8. REST OF EUROPE
      • 9.2.6.8.1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. ASIA-PACIFIC BOTULINUM TOXIN MARKET DRIVERS
    • 9.3.3. ASIA-PACIFIC BOTULINUM TOXIN MARKET CHALLENGES
    • 9.3.4. ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
    • 9.3.5. KEY PLAYERS IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
    • 9.3.6. COUNTRY ANALYSIS
      • 9.3.6.1. CHINA
      • 9.3.6.1.1. CHINA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.2. JAPAN
      • 9.3.6.2.1. JAPAN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.3. INDIA
      • 9.3.6.3.1. INDIA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.4. SOUTH KOREA
      • 9.3.6.4.1. SOUTH KOREA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.5. SINGAPORE
      • 9.3.6.5.1. SINGAPORE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.6. THAILAND
      • 9.3.6.6.1. THAILAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.7. AUSTRALIA & NEW ZEALAND
      • 9.3.6.7.1. AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.8. REST OF ASIA-PACIFIC
      • 9.3.6.8.1. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. REST OF WORLD BOTULINUM TOXIN MARKET DRIVERS
    • 9.4.3. REST OF WORLD BOTULINUM TOXIN MARKET CHALLENGES
    • 9.4.4. REST OF WORLD BOTULINUM TOXIN REGULATORY FRAMEWORK
    • 9.4.5. KEY PLAYERS IN REST OF WORLD BOTULINUM TOXIN MARKET
    • 9.4.6. REGIONAL ANALYSIS
      • 9.4.6.1. LATIN AMERICA
      • 9.4.6.1.1. LATIN AMERICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.4.6.2. MIDDLE EAST & AFRICA
      • 9.4.6.2.1. MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS
    • 10.1.4. BUSINESS EXPANSIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ABBVIE
      • 10.2.1.1. COMPANY OVERVIEW
      • 10.2.1.2. PRODUCT LIST
      • 10.2.1.3. STRENGTHS & CHALLENGES
    • 10.2.2. CANDELA MEDICAL
      • 10.2.2.1. COMPANY OVERVIEW
      • 10.2.2.2. PRODUCT LIST
      • 10.2.2.3. STRENGTHS & CHALLENGES
    • 10.2.3. DAEWOONG PHARMACEUTICAL CO LTD
      • 10.2.3.1. COMPANY PROFILE
      • 10.2.3.2. PRODUCT LIST
      • 10.2.3.3. STRENGTHS & CHALLENGES
    • 10.2.4. EVOLUS INC
      • 10.2.4.1. COMPANY OVERVIEW
      • 10.2.4.2. PRODUCT LIST
      • 10.2.4.3. STRENGTHS & CHALLENGES
    • 10.2.5. GALDERMA
      • 10.2.5.1. COMPANY OVERVIEW
      • 10.2.5.2. PRODUCT LIST
      • 10.2.5.3. STRENGTHS & CHALLENGES
    • 10.2.6. HUGEL INC
      • 10.2.6.1. COMPANY OVERVIEW
      • 10.2.6.2. PRODUCT LIST
      • 10.2.6.3. STRENGTHS & CHALLENGES
    • 10.2.7. IPSEN
      • 10.2.7.1. COMPANY OVERVIEW
      • 10.2.7.2. PRODUCTS / SERVICES LIST
      • 10.2.7.3. STRENGTHS & CHALLENGES
    • 10.2.8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
      • 10.2.8.1. COMPANY OVERVIEW
      • 10.2.8.2. PRODUCT LIST
      • 10.2.8.3. STRENGTHS & CHALLENGES
    • 10.2.9. MEDYTOX INC
      • 10.2.9.1. COMPANY OVERVIEW
      • 10.2.9.2. PRODUCT LIST
      • 10.2.9.3. STRENGTHS & CHALLENGES
    • 10.2.10. MERZ PHARMA
      • 10.2.10.1. COMPANY OVERVIEW
      • 10.2.10.2. PRODUCT LIST
      • 10.2.10.3. STRENGTHS & CHALLENGES
    • 10.2.11. REVANCE THERAPEUTICS INC
      • 10.2.11.1. COMPANY OVERVIEW
      • 10.2.11.2. PRODUCT LIST
    • 10.2.12. US WORLDMEDS LLC
      • 10.2.12.1. COMPANY OVERVIEW
      • 10.2.12.2. PRODUCT LIST

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN
  • TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
  • TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 5: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 6: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 7: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 8: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 11: GLOBAL WOMEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 12: GLOBAL WOMEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 13: GLOBAL MEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 14: GLOBAL MEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 15: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 16: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 17: GLOBAL MEDICAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 18: GLOBAL MEDICAL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 20: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 21: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 22: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 23: GLOBAL MUSCLE SPASM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 24: GLOBAL MUSCLE SPASM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 25: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 26: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 27: GLOBAL HYPERHIDROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 28: GLOBAL HYPERHIDROSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 29: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 30: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 31: GLOBAL AESTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 32: GLOBAL AESTHETIC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 33: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 35: GLOBAL CROW'S FEET MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 36: GLOBAL CROW'S FEET MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 37: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 38: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 39: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 40: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 41: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 42: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 43: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 44: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 45: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 46: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 47: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 48: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 49: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 50: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 51: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 53: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 54: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 55: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 56: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 57: NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
  • TABLE 58: KEY PLAYERS OPERATING IN NORTH AMERICA BOTULINUM TOXIN MARKET
  • TABLE 59: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 60: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 61: EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
  • TABLE 62: KEY PLAYERS OPERATING IN EUROPE BOTULINUM TOXIN MARKET
  • TABLE 63: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 64: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 65: ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
  • TABLE 66: KEY PLAYERS OPERATING IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
  • TABLE 67: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 68: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 69: REST OF WORLD BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
  • TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD BOTULINUM TOXIN MARKET
  • TABLE 71: LIST OF ACQUISITIONS
  • TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 73: LIST OF PARTNERSHIPS
  • TABLE 74: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
  • FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY
  • FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA
  • FIGURE 6: GROWTH PROSPECT MAPPING FOR BRAZIL
  • FIGURE 7: MARKET MATURITY ANALYSIS
  • FIGURE 8: MARKET CONCENTRATION ANALYSIS
  • FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
  • FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)
  • FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)
  • FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022
  • FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2032 (IN $ MILLION)
  • FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY MEN, 2023-2032 (IN $ MILLION)
  • FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
  • FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2032 (IN $ MILLION)
  • FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022
  • FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2032 (IN $ MILLION)
  • FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2032 (IN $ MILLION)
  • FIGURE 20: GLOBAL BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2032 (IN $ MILLION)
  • FIGURE 21: GLOBAL BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2032 (IN $ MILLION)
  • FIGURE 22: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2032 (IN $ MILLION)
  • FIGURE 23: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2032 (IN $ MILLION)
  • FIGURE 24: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022
  • FIGURE 25: GLOBAL BOTULINUM TOXIN MARKET, BY CROW'S FEET, 2023-2032 (IN $ MILLION)
  • FIGURE 26: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2032 (IN $ MILLION)
  • FIGURE 27: GLOBAL BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2032 (IN $ MILLION)
  • FIGURE 28: GLOBAL BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2032 (IN $ MILLION)
  • FIGURE 29: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2032 (IN $ MILLION)
  • FIGURE 30: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
  • FIGURE 31: GLOBAL BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2032 (IN $ MILLION)
  • FIGURE 32: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2032 (IN $ MILLION)
  • FIGURE 33: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
  • FIGURE 34: NORTH AMERICA BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
  • FIGURE 35: UNITED STATES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 36: CANADA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 37: EUROPE BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
  • FIGURE 38: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 39: GERMANY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 40: FRANCE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 41: ITALY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 42: SPAIN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 43: NORDIC COUNTRIES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 44: POLAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 45: REST OF EUROPE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 46: ASIA-PACIFIC BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
  • FIGURE 47: CHINA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 48: JAPAN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 49: INDIA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 50: SOUTH KOREA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 51: SINGAPORE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 52: THAILAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 53: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 54: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 55: REST OF WORLD BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
  • FIGURE 56: LATIN AMERICA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 57: MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)